← SynDRA
TAK-901
SynDRA canonical compound SYN0038175 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | AURKA | AURKB |
|---|
| Mechanism of action | Aurora kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- AURKB INHIBITOR
- Serine/threonine-protein kinase Aurora-B inhibitor
- aurora kinase inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- AAK1
- PDGFRB
- PIM1
- PHKG2
- PGRMC1
- PFKP
- PEBP1
- PDXK
- PASK
- PIP4K2A
- PAK6
- PAK4
- PAK2
- PAICS
- OPA1
- OLA1
- PIM2
- PIP4K2C
- PRKCZ
- PRKAG1
- PRKCI
- PRKCD
- PRKCB
- PRKCA
- PRKAR2A
- PRKAG2
- PRKACG
- PKMYT1
- PRKACB
- PRKACA
- PRKAA1
- PLK4
- PKN2
- PKN1
- NUAK2
- NTRK1
- NQO2
- MAPK9
- MAT2A
- MARK4
Cross-references
Synonyms
- TAK 901
- TAK901
- UNII-DM9UIR23R7
- 5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-N-(1-methylpiperidin-4-yl)-9H-pyrido[2,3-b]indole-7-carboxamide
- DM9UIR23R7
- 5-[3-(Ethylsulfonyl)phenyl]-3,8-dimethyl-N-(1-methyl-4-piperidinyl)-9H-pyrido[2,3-b]indole-7-carboxamide
- C28H32N4O3S
- 5-[3-(ethanesulfonyl)phenyl]-3,8-dimethyl-N-(1-methylpiperidin-4-yl)-9H-pyrido[2,3-b]indole-7-carboxamide
- 5-(3-ethylsulfonylphenyl)-3,8-dimethyl-N-(1-methylpiperidin-4-yl)-9H-pyrido[2,3-b]indole-7-carboxamide
- cc-11
- MLS006010174
- RefChem:890311
- Aurora B Serine/Threonine Kinase Inhibitor TAK-901
- MFCD18782651
- SCHEMBL645679
- orb1700797
- SCHEMBL29389353
- SCHEMBL29478939
- SCHEMBL29551559
- EX-A874
- WKDACQVEJIVHMZ-UHFFFAOYSA-N
- GLXC-03276
- HMS3656F17
- EBC-11429
- NSC762151
- NSC803712
- s2718
- AKOS005266666
- CCG-269734
- CS-0243
- FT27989
- NSC-762151
- NSC-803712
- SB19309
- SDCCGSBI-0654430.P001
- NCGC00346645-01
- NCGC00346645-03
- NCGC00346645-04
- NCGC00346645-05
Look up TAK-901 in the interactive SynDRA portal →